Login to Your Account

Generic drug, device inspection riders added to House user fee bill

By Mark McCarty
Regulatory Editor

Thursday, May 18, 2017

Despite repeated calls for a fix for the drug pricing problem that held up the proceedings, a House subcommittee met May 18 to mark up FDA user fee legislation, which is headed to the full Energy and Commerce Committee with amendments that would boost generic drug competition and press the agency on medical device inspections.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription